MedTrace Logo

the Effect of Calcium Dobesilate on Non Dialysis Patients With CKD

NCT03427944 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-02-14

No results posted yet for this study

Summary

To investigate the feasibility of calcium dobesilate in the treatment of microvascular injury provides new ideas and theoretical basis for the prevention and treatment of chronic renal failure.

Conditions

  • Chronic Renal Failure

Interventions

DRUG

Calcium Dobesilate group

Calcium dobesilate was used to treat patients with chronic renal failure on the basis of conventional treatment.

DRUG

Conventional Treatment group

Conventional treatment were used to treat patients with chronic renal failure.

Sponsors & Collaborators

  • The Affiliated Hospital of Xuzhou Medical University

    lead OTHER

Principal Investigators

  • Dong Sun, MD · The Affiliated Hospital of Xuzhou Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03427944 on ClinicalTrials.gov